Evidence map›Paper›PMID 31755816›Full record

ReviewSurgical infections2020

Sepsis 2019: What Surgeons Need to Know.

Vanessa P Ho, Haytham Kaafarani, Rishi Rattan, Nicholas Namias, Heather Evans, Tanya L Zakrison

Open access · bronzeAbstract readReview
In one paragraph

Review in Surgical infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Beneficial effect of Xuebijing againstFrontiers in pharmacology · 2022
    Article
  9. Article
  10. Artificial Intelligence: The New Alexander Fleming.Healthcare informatics research · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Vanessa P HoDivision of Trauma, Critical Care, Burns, and Acute Care Surgery, MetroHealth Medical Center, Cleveland, Ohio.
Haytham KaafaraniTrauma, Emergency Surgery and Surgical Critical Care, Harvard Medical School, Boston, Massachusetts.
Rishi RattanDivision of Trauma and Surgical Critical Care, University of Miami Miller School of Medicine, Miami, Florida.
Nicholas NamiasDivision of Trauma and Surgical Critical Care, University of Miami Miller School of Medicine, Miami, Florida.
Heather EvansDivision of General & Acute Care Surgery, Medical University of South Carolina, Charleston, South Carolina.
Tanya L ZakrisonSection for Trauma and Acute Care Surgery, The University of Chicago Medicine, Chicago, Illinois.
University of Miami · USHarvard University · USMedical University of South Carolina · USMetroHealth · USUniversity of Chicago · US

Funding

Institutional Career Development CoreKL2TR002547 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI DWEIK, RAED A. · 2018 to 2022
$7.7M
NCATS NIH HHS KL2 TR002547
6 · The paper itself

Abstract

The definition of sepsis continues to be as dynamic as the management strategies used to treat this. Sepsis-3 has replaced the earlier systemic inflammatory response syndrome (SIRS)-based diagnoses with the rapid Sequential Organ Failure Assessment (SOFA) score assisting in predicting overall prognosis with regards to mortality. Surgeons have an important role in ensuring adequate source control while recognizing the threat of carbapenem-resistance in gram-negative organisms. Rapid diagnostic tests are being used increasingly for the early identification of multi-drug-resistant organisms (MDROs), with a key emphasis on the multidisciplinary alert of results. Novel, higher generation antibiotic agents have been developed for resistance in ESKCAPE (

Indexed as

Drug Resistance, Multiple, BacterialDuration of TherapyAcinetobacter baumanniiAcinetobacter InfectionsAngiotensin IIAnti-Bacterial AgentsAntioxidantsAscorbic AcidCarbapenem-Resistant EnterobacteriaceaeEnterobacteriaceae InfectionsEnterococcus faeciumEnzyme InhibitorsGram-Positive Bacterial InfectionsHumansKlebsiella InfectionsKlebsiella pneumoniaeAngiotensin IIAnti-Bacterial AgentsAntioxidantsAscorbic AcidEnzyme InhibitorsMethylene BlueProcalcitoninThiamineVasoconstrictor AgentsVitamin B ComplexMDROsprocalcitoninsepsissource controlvitamin C

Identifiers

PMID31755816
PMCPMC7366317
OpenAlexW2990792846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.